SciTech Development

SciTech Development is a clinical-stage oncology pharmaceutical company focused on developing and delivering innovative cancer treatments. Their lead product, ST-001, utilizes a nanoparticle delivery platform to overcome bioavailability issues of fenretinide, a synthetic retinoid derivative, effectively targeting and killing cancer cells. This approach addresses unmet needs in oncology by maximizing the drug's potential while minimizing toxicities.

Buy Funded Startups lists

Funding Round: Convertible Note

Funding Amount: $3.2M

Date: 04-Jun-2024

Investors: Storm Lake Capital, Pointe Angels, alongside new and existing accredited investors

Markets: Oncology, Pharmaceutical

HQ: Grosse Pointe Farms, Michigan, United States

Founded:

Website: http://www.scitechsdp.com/

LinkedIn: https://www.linkedin.com/company/scitechdevelopment

Twitter:

Instagram: